questionText: To ask the Secretary of State for Health and Social Care, with reference to the Answer of 15 June 2026 to Question 7593, whether his Department plans to assess the adequacy of national clinical arrangements for identifying, recording and acting on patient psychiatric history, psychotropic medication use and previous psychiatric adverse drug reactions before the initiation of preventive migraine treatment.
answerText: The Department has no plans to make a further assessment beyond the position set out in the Answer of 15 June 2026 to Question 7593.
heading: Migraines: Drugs